Winning combination: the additive/synergistic benefits of IVIg in corticosteroid refractory optic neuritis

Eur J Neurol. 2008 Nov;15(11):1145. doi: 10.1111/j.1468-1331.2008.02257.x.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use*
  • Anti-Inflammatory Agents / therapeutic use
  • Clinical Trials as Topic
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Resistance / drug effects*
  • Drug Resistance / immunology
  • Drug Synergism
  • Humans
  • Immunoglobulins, Intravenous / administration & dosage*
  • Immunologic Factors / administration & dosage
  • Methylprednisolone / therapeutic use
  • Multiple Sclerosis / complications*
  • Multiple Sclerosis / immunology
  • Optic Neuritis / drug therapy*
  • Optic Neuritis / immunology
  • Optic Neuritis / physiopathology
  • Treatment Outcome

Substances

  • Adrenal Cortex Hormones
  • Anti-Inflammatory Agents
  • Immunoglobulins, Intravenous
  • Immunologic Factors
  • Methylprednisolone